Matches in SemOpenAlex for { <https://semopenalex.org/work/W606576888> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W606576888 abstract "Abstract Cystic fibrosis is a single gene disorder, inherited in an autosomal recessive manner. Occurring CFTR defect leads predominantly to production of excessively viscous mucus, dysfunction of enzymatic activity of the pancreas and increased sodium chloride content in sweat. Currently used symptomatic treatment is associated with a significant reduction in the quality of life of the patient. The “high throughput screening” technique resulted in the detection of two groups of potential medications – potentiators and amplifiers. Mutations in the CFTR gene are divided into 6 classes, depending on whether the disturbance is in the translation process, protein maturation, or CFTR channel not fulfilling its function. The first class of mutations is associated with the formation of premature STOP codon, a compound which “masks” the process is ataluren. Mutations in the second class guide misfolded protein to degradation pathway. Correctors correct protein folding process and prevent its degradation. Mutation classes III to VI are associated with abnormal operation of the CFTR channel in the cell membrane. Amplifiers improve the function of the channel. Ivacaftor (VX-770) is a transmembrane transport regulator approved for treating patients with G551D, G1244E, G1349D, G178R, G551S, S1255P, S549N and S549R mutations. The second method of treatment is the gene therapy. By using viral and non-viral vectors, new copies of gene free of the mutation causing CF are introduced into the cells. The proteins encoded by these genes allow restoration of normal cell function. However, at the moment this form of treatment is in clinical trials." @default.
- W606576888 created "2016-06-24" @default.
- W606576888 creator A5020399381 @default.
- W606576888 creator A5077190197 @default.
- W606576888 date "2015-09-01" @default.
- W606576888 modified "2023-09-27" @default.
- W606576888 title "Perspektywy leczenia przyczynowego mukowiscydozy" @default.
- W606576888 cites W1964630716 @default.
- W606576888 cites W1969697265 @default.
- W606576888 cites W1975574920 @default.
- W606576888 cites W1980652538 @default.
- W606576888 cites W1983796108 @default.
- W606576888 cites W1986240040 @default.
- W606576888 cites W1986901184 @default.
- W606576888 cites W1988003798 @default.
- W606576888 cites W2004328267 @default.
- W606576888 cites W2025049903 @default.
- W606576888 cites W2026026319 @default.
- W606576888 cites W2060123265 @default.
- W606576888 cites W2065926866 @default.
- W606576888 cites W2067591505 @default.
- W606576888 cites W2069289373 @default.
- W606576888 cites W2071226544 @default.
- W606576888 cites W2071407356 @default.
- W606576888 cites W2071835528 @default.
- W606576888 cites W2083678737 @default.
- W606576888 cites W2093904931 @default.
- W606576888 cites W2098498572 @default.
- W606576888 cites W2121996960 @default.
- W606576888 cites W2122967691 @default.
- W606576888 cites W2135020982 @default.
- W606576888 cites W2138761519 @default.
- W606576888 cites W2140868856 @default.
- W606576888 cites W2147926061 @default.
- W606576888 cites W2150297577 @default.
- W606576888 cites W2157305393 @default.
- W606576888 cites W2159814661 @default.
- W606576888 cites W2170032136 @default.
- W606576888 cites W2178083247 @default.
- W606576888 cites W2217066197 @default.
- W606576888 doi "https://doi.org/10.1016/j.pepo.2015.06.005" @default.
- W606576888 hasPublicationYear "2015" @default.
- W606576888 type Work @default.
- W606576888 sameAs 606576888 @default.
- W606576888 citedByCount "0" @default.
- W606576888 crossrefType "journal-article" @default.
- W606576888 hasAuthorship W606576888A5020399381 @default.
- W606576888 hasAuthorship W606576888A5077190197 @default.
- W606576888 hasConcept C104317684 @default.
- W606576888 hasConcept C126322002 @default.
- W606576888 hasConcept C143065580 @default.
- W606576888 hasConcept C164718446 @default.
- W606576888 hasConcept C2776502428 @default.
- W606576888 hasConcept C2776938444 @default.
- W606576888 hasConcept C2778428886 @default.
- W606576888 hasConcept C501734568 @default.
- W606576888 hasConcept C502942594 @default.
- W606576888 hasConcept C54355233 @default.
- W606576888 hasConcept C71924100 @default.
- W606576888 hasConcept C86803240 @default.
- W606576888 hasConcept C95444343 @default.
- W606576888 hasConcept C98274493 @default.
- W606576888 hasConceptScore W606576888C104317684 @default.
- W606576888 hasConceptScore W606576888C126322002 @default.
- W606576888 hasConceptScore W606576888C143065580 @default.
- W606576888 hasConceptScore W606576888C164718446 @default.
- W606576888 hasConceptScore W606576888C2776502428 @default.
- W606576888 hasConceptScore W606576888C2776938444 @default.
- W606576888 hasConceptScore W606576888C2778428886 @default.
- W606576888 hasConceptScore W606576888C501734568 @default.
- W606576888 hasConceptScore W606576888C502942594 @default.
- W606576888 hasConceptScore W606576888C54355233 @default.
- W606576888 hasConceptScore W606576888C71924100 @default.
- W606576888 hasConceptScore W606576888C86803240 @default.
- W606576888 hasConceptScore W606576888C95444343 @default.
- W606576888 hasConceptScore W606576888C98274493 @default.
- W606576888 hasLocation W6065768881 @default.
- W606576888 hasOpenAccess W606576888 @default.
- W606576888 hasPrimaryLocation W6065768881 @default.
- W606576888 isParatext "false" @default.
- W606576888 isRetracted "false" @default.
- W606576888 magId "606576888" @default.
- W606576888 workType "article" @default.